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ncreased renal sympathetic tone in the deoxycorticosterone acetate-salt rats augmented renal Na + retention and was associated with the development of hypertension. 1 Moreover, Mu et al 2 showed that norepinephrine or isoproterenol infusion significantly raised blood pressure during increased Na + intake. The hypertension induced by sympathetic stimulation may be partially caused by high NaCl cotransporter (NCC) activity because isoproterenol perfusion increased the thiazide-sensitive NCC activity in the kidney, especially during high salt intake. This notion was also supported by a finding reported by Terker et al 3 demonstrating that the mice acutely treated with norepinephrine or isoproterenol increased NCC phosphorylation (an indication of NCC activation). Because the activation of NCC induced by sympathetic stimulation was also observed in AT1R (angiotensin II type 1 receptor) knockout mice, this indicated that AT1R was not involved in mediating sympathetic stimulation of NCC. 3 Furthermore, they have reported that chronic norepinephrine infusion caused salt-sensitive hypertension and activated NCC. Although these studies have convincingly established the relationship between sympathetic stimulation and upregulated NCC activity, the mechanism by which norepinephrine infusion activates NCC is not completely understood. It has been reported that the sympathetic stimulation activated WNK4 (with-no-lysine kinase 4) through epigenetic modulation and that the activation of WNK4 was responsible for the upregulation of NCC. 2 WNK4 is a Cl − -sensitive kinase, and the basolateral K + channel activity in the distal convoluted tubule (DCT) has been shown to affect WNK4 activity by altering the cell membrane potential. 4, 5 The DCT cell membrane potential is determined by inwardly rectifying K + channel 4.1 (Kir4.1) encoded by Kcnj10. 6, 7 Although Kir4.1 is also expressed in the basolateral membrane of thick ascending limb, connecting tubule, and cortical collecting duct, [8] [9] [10] [11] [12] [13] [14] Kir4.1 is the only type of K + channel in the DCT, and it contributes to the basolateral K conductance. 6, 7 Kir4.1 interacts with Kir5.1 (encoded by Kcnj16) to form a 40 pS heterotetrameric K + channel under physiological conditions. 12, 15 Although Kir4.1 is responsible for providing the Abstract-The stimulation of β-adrenergic receptor increases thiazide-sensitive NaCl cotransporter (NCC), an effect contributing to salt-sensitive hypertension by sympathetic stimulation. We now test whether the stimulation of β-adrenergic receptor-induced activation of NCC is achieved through activating basolateral Kir4.1 in the distal convoluted tubule (DCT). Application of norepinephrine increased the basolateral 40 pS K + channel (Kir4.1/Kir5.1 heterotetramer) in the DCT. The stimulatory effect of norepinephrine on the K + channel was mimicked by cAMP analogue but abolished by inhibiting PKA (protein kinase A). Also, the effect of norepinephrine on the K + channel in the DCT was recapitulated by isoproterenol but not by α-adrenergic agonist and blocked by propranolol, suggesting that norepinephrine effect on the K + channel was mediated by β-adrenergic receptor. The whole-cell recording shows that norepinephrine and isoproterenol increased DCT K + currents and shifted the K + current (I K ) reversal potential to negative range (hyperpolarization). Continuous norepinephrine perfusion (7 days) increased DCT K + currents, hyperpolarized I K reversal potential, and increased the expression of total NCC/phosphorylated NCC, but it had no significant effect on the expression of NKCC2 (type 2 Na-Cl-K cotransporter) and ENaC-α (epithelial Na channel-α subunit). Renal clearance study demonstrated that norepinephrine perfusion augmented thiazide-induced urinary Na + excretion only in wild-type but not in kidney-specific Kir4.1 knockout mice, suggesting that Kir4.1 is required for mediating the effect of norepinephrine on NCC. However, norepinephrine perfusion did not affect urinary K + excretion. We conclude that the stimulation of β-adrenergic receptor activates the basolateral Kir4.1 in the DCT and that the activation of Kir4.1 is required for norepinephrine-induced stimulation of NCC. (Hypertension.
basolateral K + conductance, the role of Kir5.1 in the regulation of Kir4.1/Kir5.1 heterotetramer is convincingly established as an important regulatory subunit which affects the transport function in the DCT. [16] [17] [18] Because this 40 pS K + heterotetramer is the only type of K + channel expressed in the basolateral membrane of the DCT, the Kir4.1/Kir5.1 channel plays a dominant role in determining the negativity of the membrane potential. 9, 19, 20 The notion that Kir4.1/5.1 heterotetramer plays a key role in regulating NCC activity in the DCT was strongly suggested by the finding that the deletion of kcnj10 strikingly reduced the expression of total NCC and phosphorylated NCC (pNCC). 7, 9 Because β-adrenergic receptor is expressed in the DCT, 21 it raises the possibility that the activation of the basolateral 40 pS K + channel in the DCT may be required for NCC activation induced by sympathetic stimulation. Thus, the aim of the present study is to test the role of Kir4.1 in the DCT in mediating the effect of norepinephrine on NCC.
Methods
The authors declare that all supporting data and detailed methods including animal preparation, electrophysiology, Western blot, and renal clearance method are available within the article (and its onlineonly Data Supplement).
Animals
C57BL/6 mice (either sex, 12 weeks old) and kidney-specific conditional Kcnj10 −/− or Kir4.1 knockout (Ks-Kir4.1 KO) mice were used in the present study. C57/BL/6 mice were purchased from the Second Hospital of Harbin Medical University or Jackson Laboratory (Bar Harbor, ME). KS-Kir4.1 KO mice were bred at New York Medical College for the experiments, and the procedure for generating Ks-Kir4.1 KO mice is described in the online-only Data Supplement. The mice were fed a normal K + diet (1% KCl) and had free access to water. In some experiments, the mice received norepinephrine perfusion for 7 days (2.5 mg kg −1 d −1 ) through a subcutaneously installed osmotic minipump. The preparation of DCT for the patch-clamp experiments has been described in detail in the online-only Data Supplement.
To examine the effect of norepinephrine on the basolateral Kir4.1/5.1 in the DCT, we used both single-channel and whole-cell recording techniques. For single-channel recording, the experiments were performed in both early part of the DCT (DCT1) and the late part of the DCT (DCT2). For the whole-cell recording, the experiments were performed in the DCT1 to avoid the contamination of ROMK (Kir1.1) contamination. As shown in Figure S1A in the online-only Data Supplement, ROMK channel activity is expressed only in the DCT2 but not in the DCT1. This is confirmed by the patch-clamp experiments in which TPNQ (tertiapin-Q, a ROMK inhibitor)-sensitive K currents were measured at −40 mV in the DCT1 and DCT2 with the whole-cell recording. From the inspection of Figure S1B and S1C, it is apparent that TPNQ (400 nmol/L)-sensitive ROMK currents were only detected in the DCT2 (1030±70 pA) but not in the DCT1 (n=6). Thus, the whole-cell K + currents measured in the DCT1 is completely composed of Kir4.1 channel activity. Morphological appearance of DCT1 is slightly different from that of DCT2. Figure S1A shows the image of the isolated DCT demonstrating that the tubule surface of mouse DCT2 appears to be less smooth than that of DCT1. Thus, we are able to clearly identify the DCT1 and DCT2 under microscope and to patch on corresponding DCT segment.
Electrophysiology
A Narishige electrode puller (Narishige, Japan) was used to manufacture the patch-clamp pipettes from Borosilicate glass (1.7-mm outside diameter). The resistance of the pipette was 5 (for single-channel recording) or 2 MΩ (for whole-cell recording) when it was filled with solution containing (in mmol/L) 140 KCl, 1.8 MgCl 2 , and 10 HEPES (titrated with KOH to pH 7.4). The details for the single-channel and whole-cell recordings are described in the online-only Data Supplement.
Immunoblotting
Whole kidney protein extract was obtained from frozen kidney homogenized in a buffer containing (in mmol/L) 250 sucrose, 50 Tris-HCl (pH 7.5), 1 EDTA, 1 EGTA, 1 DTT supplemented with phosphatase and protease inhibitor cocktails (pH 7.6). Protein (60 or 80 μg) was separated on 8% to 12% (wt/vol) Tris-Glycine geland transferred to nitrocellulose membrane. The membranes were incubated 2 hours with 5% nonfat dry milk in Tris-buffered saline-Tween and then incubated overnight at 4°C with anti-NCC (1:1000, No: AB3553; EMD Millipore), anti-pNCC at threonine-53 (1:1000, No: p1311-53; Phosphosolutions), anti-NKCC2 (anti-type 2 Na-Cl-K cotransporter; 1:1000, No: AB171747; Abcam), and anti-ENaC-α (epithelial Na channel-α subunit; 1: 1000, No: SAB5200105; Sigma) antibodies. Protein Simple infrared imaging system (FluorChem R) was used to capture the images.
Material and Statistical Analysis
All chemicals including norepinephrine, phenylephrine, isoproterenol, epinephrine, propranolol, db-cAMP, H 89 dihydrochloride hydrate (H89), and polyclone antibodies for ENaC-α were purchased from Sigma Chemicals (St Louis, MO). NCC, pNCC, and NKCC2 were purchased from EMD Millipore, Phosphosolutions, and Abcam, respectively. Data were analyzed using Student t test for comparisons between 2 groups or 1-way ANOVA for comparisons among >2 groups. P values <0.05 were considered statistically significant. Data are presented as the mean±SEM.
Results
We first used the single-channel recording to examine the effect of norepinephrine on the basolateral 40 pS K + channel, which is known as a Kir4.1 and Kir5.1 heterotetramer. 9 Although a 20 pS K + channel (Kir4.1 homotetramer) could also be detected in <1% patches, the 40 pS K + channels are overwhelmingly the main type of K + channel in the basolateral membrane of the DCT. Thus, no efforts were made to examine the effect of norepinephrine on the 20 pS K + channel in the basolateral membrane of the DCT in the present study. Figure 1A is a typical single-channel recording showing the effect of norepinephrine on the K + channel in a cellattached patch. The application of norepinephrine at 1 nmol/L slightly increased the K + channel activity (defined by NP o ) in the DCT (control, 1.62±0.1, n=11 and 1 nmol/L norepinephrine, 1.9±0.2, n=5), although it was not significant. However, 10 nmol/L norepinephrine significantly stimulated the basolateral 40 pS K + channels and increased NP o to 2.2±0.1 (n=5) ( Figure 1B ). Results summarized in Figure 1B show that the effect of norepinephrine on the K + channel was dose dependent and that raising norepinephrine concentrations to 0.1, 1, and 10 μmol/L increased the basolateral 40 pS K + channel activity to 2.92±0.2 (n=10), 3.23±0.2 (n=5), and 3.35±0.2 (n=4), respectively. A previous study had demonstrated that the stimulation of PKA (protein kinase A) activated the basolateral 40 pS K + channel in the thick ascending limb. 22 Because this 40 pS K + channel in the thick ascending limb was also a Kir4.1/Kir5.1 heterotetramer, 8 we suspected that PKA might also stimulate the basolateral K + channel in the DCT. From the inspection of Figure S2 , it is apparent that db-cAMP (500 μmol/L), a membrane-permeable cAMP analogue, significantly stimulated the K + channel in the DCT and increased NP o from 1.70±0.16 to 2.97±0.2 (n=8).
To examine whether the stimulatory effect of norepinephrine on the K + channel in the DCT was also mediated by PKA, we examined the effect of 0.1 μmol/L norepinephrine on the basolateral 40 pS K + channel in the presence of (5 μmol/L) H89, an inhibitor of PKA ( Figure S3 ). Although the inhibition of PKA with H89 (5 μmol/L) had no significant effect on the basolateral 40 pS K + channel activity, it abolished the effect of norepinephrine (0.1 μmol/L) on the K + channel. Results summarized in Figure 1C show that mean NP o of the K + channel was 1.84±0.19 (n=7) in the group treated with H89+norepinephrine, and it was not significantly different from the control (1.64±0.14) or H89 alone (1.8±0.19) ( Figure 1C ). The notion that PKA mediates the effect of sympathetic stimulation of the basolateral 40 pS K + channel was also supported by the finding that inhibition of PKA abolished the effect of epinephrine on the basolateral 40 pS K + channel in the DCT. Figure 1C shows that application of epinephrine (1 μmol/L) increased K + channel activity to 3.05±0.2 (n=7), but it failed to stimulate K + channel in the presence of H89 (NP o =1.75±0. 19) .
The notion that β-adrenergic receptor-mediated the stimulatory effect of norepinephrine on the basolateral K + channel in the DCT was further suggested by experiments in which the effect of norepinephrine on the basolateral K + channel activity was examined in the DCT treated with 10 μmol/L propranolol ( Figure S4A ). Although propranolol alone did not significantly affect the channel activity (control NP o , 1.65±0.22; propranolol, 1.64±0.21), the application of β-adrenergic antagonist abolished the effect of norepinephrine. Results from 6 experiments are summarized in Figure S4B showing that norepinephrine failed to stimulate the 40 pS K + channel in the DCT treated with propranolol (NP o , 1.74±0.15). Also, 100 nmol/L isoproterenol, a specific β-adrenergic agonist, mimicked the effect of norepinephrine and stimulated the basolateral K + channels in the DCT ( Figure 2A ) and increased NP o to 2.9±0.2 (n=8) ( Figure 2B ). In contrast, phenylephrine (5 μmol/L), a specific α-adrenergic agonist, failed to increase the K + channel activity ( Figure 2C ) and NP o was 1.88±0.2 (n=5) which was not significantly different from the control ( Figure 2B ). Also, the stimulatory effect of isoproterenol was blocked by propranolol ( Figure 2D ) because isoproterenol failed to increase the channel activity in the DCT treated with propranolol (NP o , 1.75±0.21) (n=6), a value not significantly different from the control (1.65±0.22) and propranolol (1.64±0.21). Thus, the effect of norepinephrine on the basolateral 40 pS K + channel in the DCT was mediated by β-adrenergic receptor and cAMP-dependent pathway.
Norepinephrine-induced activation of the 40 pS K + channel is expected to increase the basolateral K + conductance in the DCT. Thus, we used whole-cell recording technique to measure the K + currents in the early portion of the DCT (DCT1). As mentioned above, the reason to measure K + conductance in the DCT1 is because of the absence of ROMK channel activity in the apical membrane of the DCT1 ( Figure  S1 ). Moreover, the Kir4.1 is the only type of K + channel providing the basolateral K + conductance along the whole DCT. 6, 7 Thus, the whole-cell K + conductance would be identical to Kir4.1 activity. Because the deletion of Kir4.1 inhibited the expression of NCC along whole DCT, 7 this indicates that Kir4.1 activity regulates NCC activity in the whole DCT segment. Thus, the observation made in the DCT1 about Kir4.1 channel should also apply to the DCT2. Figure 3A is a set of recordings showing the effect of 0.1 μmol/L norepinephrine or isoproterenol on the whole-cell K + currents in the DCT using step protocol (clamped from −60 to 60 mV at 20 mV step). It is apparent that norepinephrine (n=8) and isoproterenol (n=8) significantly increased the whole-cell K + conductance (at −60 mV) from 1010±32 to 1440±40 pA (norepinephrine) or 1645±113 pA (isoproterenol), respectively ( Figure 3C ). Not only norepinephrine acutely increased the basolateral K + conductance in the DCT, but also it chronically increased the whole-cell K + conductance when the mice were infused with norepinephrine (2.5 mg kg
) by an osmotic pump (7 days). Figure 3B currents measured with whole-cell recording in the DCT1 of mice treated with norepinephrine for 7 days and norepinephrine infusion increased K + currents to 1890±95 pA at −60 mV (n=6) ( Figure 3B ).
Because the basolateral K + channel plays a key role in determining the negativity of the DCT membrane, K + channel activation induced by sympathetic stimulation should increase the negativity of the membrane (hyperpolarization). Thus, we used perforated whole-cell recording to measure K + current (I K ) reversal potential in the DCT (an index of membrane potential). Figure 4A is a trace showing the effect of 0.1 μmol/L norepinephrine or isoproterenol on the I K reversal potential, and Figure 4B is a trace showing the effect of norepinephrine infusion for 7 days on the I K reversal potential. It is apparent that sympathetic stimulation increased the negativity of the I K reversal potential. Results from 6 experiments summarized in Figure 4C show that norepinephrine (0.1 μmol/L), isoproterenol (0.1 μmol/L), and norepinephrine infusion hyperpolarized the DCT membrane from the control (63±1) to 70±1 (norepinephrine), 72±1 (isoproterenol), and 73±2 mV (norepinephrine infusion), respectively. Previous studies have demonstrated that a hyperpolarization in the DCT membrane was associated with the stimulation of NCC activity by activating Cl − -sensitive WNK. 5 Thus, we examined the effect of norepinephrine infusion on the expression of total NCC and pNCC. From the inspection of Figure 4D , it is apparent that norepinephrine infusion significantly increased the expression of pNCC (170±9%) and total NCC (150±7%) (n=6). The effect of norepinephrine infusion on NCC was specific because it had no significant effect on the expression of NKCC2 (n=6) in the mice treated with norepinephrine for 30 minutes (peritoneal injection) ( Figure S5A ) or for 7 days ( Figure S5B ). Also, neither acute norepinephrine treatment (30 min) ( Figure S6A ) nor 7-day norepinephrine infusion ( Figure S6B ) has significantly affected the expression of full-length ENaC-α or cleaved ENaC-α (n=6), although it had a trend to slightly increase their expression.
The notion that norepinephrine infusion stimulates NCC activity was also supported by renal clearance studies in which the effect of norepinephrine infusion on hydrochlorothiazide (HCTZ)-induced natriuresis was examined. Figure 5A is a line graph showing the results of each experiment in which urinary Na + excretion (E Na ) was measured before and after a single dose of HCTZ (25 mg/kg body weight [BW]) in wildtype (WT) mice with or without norepinephrine infusion for 7 days. A bar graph summarizing the results of 5 experiments shows that norepinephrine infusion significantly increased HCTZ-induced E Na (from 0.30±0.05 to 2.7±0.13 μEqmol/L per min per 100 g BW). In contrast, HCTZ increased E Na in the untreated mice from 0.67±0.06 to 2.31±0.10 μEqmol/L per min per 100 g BW ( Figure 5B ). Thus, HCTZ-induced E Na was significantly larger in the norepinephrine-infused mice than those in untreated mice. However, norepinephrine-induced stimulation of E Na was completely absent in Ks-Kcnj10 −/− mice which had renal phenotypes of human EAST (epilepsy, ataxia, sensorineural deafness, and tubulopathy)/Sesame syndrome including metabolic alkalosis, hypokalemia, and hypotension. 7 In addition, the Ks-Kir4.1 KO mice had a high basal level of renal Na + excretion because of the inhibition of NCC. 7 In untreated Ks-Kcnj10 −/− mice, E Na was 1.22±0.09 (basal) and 1.43±0.11 (HCTZ) μEqmol/L per min per 100 g BW (n=5), respectively ( Figure 5B ). In norepinephrineinfused Ks-Kcnj10 −/− mice, E Na was 1.14±0.2 (basal) and 1.32±0.2 (HCTZ) μEqmol/L per min per 100 g BW (n=5), respectively. Also, plasma Na + concentrations were unchanged in norepinephrine-treated or untreated WT and Ks-Kcnj10 −/− mice ( Figure S7) . Thus, the deletion of Kir4.1 abolished norepinephrine-induced stimulation of NCC activity.
We have also examined the effect of norepinephrine infusion on urinary K + excretion (E K ) in WT and in Ks-Kcnj10
−/− mice using renal clearance method. Figure 6A is a line graph showing the results of each experiment in which E K was measured before and after a single dose of HCTZ (25 mg/ kg BW) in WT mice and Ks-Kcnj10 −/− mice with or without norepinephrine treatment for 7 days. Figure 6B is a bar graph summarizing the results of 5 similar experiments. Although norepinephrine infusion stimulated NCC activity, norepinephrine infusion had no significant effect on E K in WT or in Ks-Kcnj10 −/− mice. In untreated WT mice, E K was 0.61±0.04 (basal) and 1.16±0.04 (HCTZ) μEqmol/L per min per 100 g BW. These values were not significantly different from the norepinephrine-treated mice, and E K was 0.54±0.03 (basal) and 1.14±0.04 (HCTZ) μEqmol/L per min per 100 g BW. Also, plasma K + levels were similar between untreated and norepinephrine-treated mice ( Figure S7 ). As reported previously, Ks-Kcnj10 −/− mice were K + wasting 7 ; basal E K was 1.02±0.05 (untreated) and 0.96±0.03 μEqmol/L per min per 100 g BW (norepinephrine-infused mice). Also, HCTZ did not significantly alter E K in untreated (1.07±0.05) or norepinephrine-treated Ks-Kcnj10 −/− mice (0.98±0.04 μEqmol/L per min per 100 g BW). In addition, untreated and norepinephrine-treated Ks-Kcnj10 −/− mice were similarly hypokalemic ( Figure S7 ). Thus, we confirm that norepinephrine stimulates NCC through β-adrenergic receptor and that Kir4.1 activity is required for norepinephrine-induced stimulation of NCC.
Discussion
The main finding of the present study is that norepinephrine stimulates the basolateral 40 pS K + channels and NCC in the DCT. Three lines of evidence indicate that the effect of norepinephrine on the basolateral 40 pS K + channel was mediated by stimulating β-adrenoceptor: (1) specific β-adrenergic receptor agonist but not α-adrenergic receptor agonist mimicked the effect of norepinephrine on the K + channel in the DCT; (2) The stimulatory effect of norepinephrine on the K + channel was blocked by propranolol; and (3) norepinephrineinduced stimulation of the basolateral 40 pS K + channel was mimicked by membrane-permeable cAMP analogue and inhibited by H89. Thus, our present finding strongly suggests the role of β-adrenoceptor in the stimulation of the basolateral 40 pS K + channel in the DCT. Because this 40 pS K + channel is the only type of K + channel expressed in the basolateral membrane of the DCT, 7 it is conceivable that norepinephrine-mediated stimulation of the 40 pS K + channel activity should have a significant effect on ) through a subcutaneously installed osmotic minipump. * indicates the significant difference (P<0.05). ) through a subcutaneously installed osmotic minipump. * indicates the significant difference (P<0.05).
the basolateral K + conductance and the membrane potential. Indeed, we observed that norepinephrine or isoproterenol treatment not only increased the basolateral K + conductance but also hyperpolarized the DCT membrane. This suggests that the β-adrenoceptor pathway is involved in tonic stimulation of the membrane potential in the DCT. It is well documented that the basolateral 40 pS K + channel in the DCT is composed of Kir4.1 and Kir5.1 (encoded by Kcnj16) and that Kir4.1 is a pore-forming component for the Kir4.1/Kir5.1 heterotetramer. 7, 12, 15 Thus, the present study indicates that β-adrenoceptor in the DCT plays a role in stimulating Kir4.1/Kir5.1 activity.
Not only stimulating Kir4.1 in the DCT, norepinephrine has been shown to increase NCC activity. 2, 3 This finding was also confirmed by our present experiments demonstrating that norepinephrine treatment significantly increased the expression of total NCC and pNCC. Furthermore, Mu et al 2 have shown that the effect of norepinephrine on NCC was absent in the mice treated with propranolol, suggesting that the effect of norepinephrine on NCC was mediated by stimulating the β-adrenoceptor pathway. In addition, Terker et al 3 have shown that the stimulatory effect of norepinephrine on NCC was diminished in kidney-specific OxSR1 (oxidative stress response kinase 1) knockout mice, suggesting the role of OxSR1 in mediating the effect of norepinephrine on NCC. Finally, Mu et al 2 have shown that sympathetic activation during increased dietary Na + intake increased WNK4 activity through histone modification. Thus, these studies have convincingly suggested that sympathetic stimulation-induced activation of NCC is mediated by WNK4-OxSR pathways.
Two lines of evidence suggest the possibility that Kir4.1/ Kir5.1 activity is also essential for the effect of norepinephrine on NCC, although we could not completely rule out the direct effect of norepinephrine on NCC. First, norepinephrine-induced stimulation of NCC activity was absent in Ks-Kcnj10 −/− mice. Second, norepinephrine-induced stimulation of NCC was closely correlated with norepinephrineinduced hyperpolarization of DCT membrane. Thus, we speculate that norepinephrine-induced stimulation of NCC activity may be, at least in part, the result of norepinephrineinduced activation of basolateral Kir4.1/Kir5.1 and hyperpolarization. A large body of evidence has suggested that the membrane potential in the DCT plays an important role in the regulation of NCC activity such that an increase in the membrane negativity (hyperpolarization) stimulates, whereas a decrease in membrane negativity (depolarization) inhibits NCC activity. 5, 7, 9 The mechanism by which Kir4.1/Kir5.1 activity regulates NCC activity in the DCT is possibly mediated by a Cl − -sensitive WNK-SPAK (ste20 proline/alanine-rich kinase)/OxSR pathway because the membrane potential of the DCT could affect the intracellular Cl − levels. 4, 5, 23 We have previously demonstrated that the deletion of Kir4.1 in the DCT depolarized the basolateral membrane. 7, 9 Because the DCT membrane potential provides the driving force for Cl − exit across the basolateral membrane through ClC-Kb (Cl channel Kb), 24, 25 alteration of Kir4.1/Kir5.1 activity should affect Cl − exit thereby changing intracellular Cl − (Cl i − ) concentrations and altering WNK and SPAK or OxSR activity. 4 Indeed, our previous study demonstrated that the deletion of Kir4.1 in the kidney inhibited the SPAK activity. 7 Because WNK and SPAK/OxSR are required for controlling NCC activity, [26] [27] [28] [29] [30] [31] [32] the stimulation of WNK should increase, whereas the inhibition of WNK should decrease NCC activity. Thus, norepinephrine-induced stimulation of the basolateral Kir4.1/Kir5.1 should decrease the intracellular Cl − levels thereby activating WNK-SPAK/OxSR pathway. Although it is possible that the sympathetic stimulation may have a direct effect on WNK4 activity through histone modification, 2 the norepinephrineinduced stimulation of Kir4.1/Kir5.1 should synergize the effect of norepinephrine on WNK4.
Norepinephrine-induced stimulation of NCC is expected to decrease Na + and volume delivery to the distal nephron segment thereby affecting K + excretion. However, neither renal K + excretion rate nor plasma K + level was changed in the mice treated with norepinephrine infusion for 7 days. We speculate that ENaC activity in the aldosterone-sensitive distal nephron may also be upregulated in norepinephrinetreated mice thereby enhancing K + secretion. Although the expression of ENaC-α was not statistically different in comparison to untreated mice, it is possible that norepinephrine treatment may functionally activate ENaC by PKA. It has been shown that NCC activity is functionally coupled with ENaC by PKA 33 ; PKA may stimulate ENaC thereby enhancing renal K + excretion. Further experiments were needed to check this notion. Also, norepinephrine infusion was expected to stimulate β-adrenoceptor in the skeletal muscle thereby stimulating K + uptake into the cells and the K + movement should play a role in maintaining plasma K + level in the normal range in norepinephrine-treated mice.
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Perspectives
The main finding of the present study is to demonstrate that the stimulation of β-adrenergic receptor activates the basolateral Kir4.1/Kir5.1 in the DCT and that the activation of Kir4.1 is essential for sympathetic stimulation of NCC activity. Thus, the basolateral Kir4.1 in the DCT serves as a gateway for sympathetic stimulation-induced activation of NCC. It is well documented that sympathetic stimulation is 1 important factor causing salt-sensitive hypertension and that norepinephrine-induced stimulation of NCC contributes the salt-sensitive hypertension by sympathetic stimulation. 2, 3, 35 Thus, our study provided an integrated mechanism by which sympathetic stimulation increases kidney Na + absorption. In addition, our present finding has further suggested the role in Kir4.1/Kir5.1 in mediating the effects of a variety of factors/ hormones on NCC and transepithelial Na + transport in the DCT. For instance, our previous studies have demonstrated that stimulation of angiotensin type II receptor inhibits NCC by suppressing Kir4.1/Kir5.1 in the DCT. 36 These data suggest that Kir4.1/Kir5.1 in the DCT is a key target for controlling transepithelial Na + transport. In conclusion, the stimulation of β-adrenoceptor in the DCT stimulates Kir4.1/Kir5.1 and sympathetic stimulation of basolateral Kir4.1 is essential for the activation of NCC by norepinephrine.
